Chagas Disease Treatment Market

Chagas Disease Treatment Market - Industry
Insights, Trends, Opportunity And Analysis 2025
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan
parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects
widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other
means such as blood transfusion, organ transplantation, as well as congenital and oral
transmissions. The recent past has witnessed spread of Chagas disease to developed economies
such as Europe and North America, due to migration of people from Latin America to others
countries. For instance, according a study published in National Center for Biotechnology
Information (NCBI), in 2015, 4.2% of Latin American living in European countries were
chronically affected with Chagas disease. Benznidazole is the only FDA approved treatment
indicated for the treatment of Chagas disease. However, the drug, Nifurtimox manufactured by
Bayer AG, is in the World Health Organization's (WHO) list of 'Essential Medicines' and used in
the treatment of Chagas disease.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/934
Increasing approval to Chagas disease treatment drugs is expected to drive growth of the global
Chagas disease treatment market
Benznidazole is an essential antiparasitic drug used for the treatment of Chagas disease. In April
2018, Argentinian National Administration for Drugs, Food, and Medical Technologies (ANMAT)
approved Laboratorio Elea Phoenix SA’s drug benznidazole for pediatric indication used for the
treatment of Chagas disease. Currently, Argentina has the highest number of people suffering
from Chagas disease. For instance, according to data published by Mundo Sano
(Nongovernmental foundation in Argentina), in 2017, around 7,300,000 people were exposed to
Chagas disease and about 1,600,000 were infected, in Argentina. Hence, approval of novel
drugs is expected to fuel the market growth in the near future. Such approval of Chagas disease
treatment drugs is expected to boost growth of Chagas disease treatment market in the near
future.
The global Chagas treatment disease market was valued at US$ 5.67 Mn in 2016 and is
expected to witness a CAGR of 7.3% over the forecast period (2017–2025).
Report includes chapters which deeply display the following deliverable about industry :
• Chagas Disease Treatment Market Research Objective and Assumption
• Chagas Disease Treatment Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Chagas Disease Treatment Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Chagas Disease Treatment Market, By Regions
• Chagas Disease Treatment Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Chagas Disease Treatment Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Chagas Disease Treatment Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Chagas Disease Treatment Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/chagas-disease-treatment-market-934
Market Dynamics
Rising migration of people from endemic countries to developed economies such as the U.S. and
in countries in Europe is expected to drive growth of Chagas disease treatment market. For
instance, according to the data published by Public Library of Science (PLOS), in 2012, there
are around 1,62,095 Bolivian adults living in Spain, in which about 97,215 are women (60%)
and 64,880 are men. It was estimated that out of total immigrants from Bolivia to Spain 34,202
were found to be potentially infected with Chagas disease. Furthermore, increasing R&D
activities for the development of novel treatment methods for Chagas disease is also expected to
create a lucrative environment for the market growth. For instance, in 2016, researchers from
Saint Louis University Center for Vaccine Development were working on developing a vaccine
for Chagas disease. Scientists found Th17 cells, a special type of white blood cell that
recognizes the presence of a foreign invader and helps other cells in the immune system to
attack and protects the body against Trypanosoma cruzi parasite.
Key players operating in the Chagas disease treatment market include Nortec Quimica SA,
Bayer AG, Laboratorio Elea Phoenix SA, Maprimed S.A., and Laboratório Farmacêutico de
Pernambuco S/A.
Purchase Report Here @ https://www.coherentmarketinsights.com/insight/buy-now/934
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Chagas disease is a tropical parasitic disease and is endemic in 21 countries in Latin America.

Download Report